Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 1/13/2026

Evidence‑Based Insights into Atherosclerotic Plaque Pathogenesis, Risk, and Management

1. Pathogenesis and Inflammatory Cascade

  • Endothelial injury induced by hypertension, smoking, hyperglycemia, and atherogenic lipoproteins promotes monocyte adhesion and migration into the intima, initiating plaque formation. American Heart Association (Circulation) 1
  • Activated macrophages within the plaque release matrix metalloproteinases and cathepsins that degrade extracellular matrix, thin the fibrous cap, and increase rupture susceptibility. American Heart Association (Circulation) 1
  • Oxidative stress generated by NAD(P)H oxidases produces reactive oxygen species that damage endothelial cells, enhance leukocyte adhesion, and perpetuate vascular inflammation. American Heart Association (Circulation) 1

2. Sex‑Specific Plaque Characteristics

  • Compared with women, men develop larger plaques with a higher likelihood of calcification (odds ratio ≈ 1.57), larger lipid‑rich necrotic cores (odds ratio ≈ 1.87), and more frequent intraplaque hemorrhage. European Society of Cardiology (Cardiovascular Research) 2

3. Global and Regional Disease Burden

Metric Estimate Source
Annual cardiovascular deaths in Europe ~5 million European Society of Nuclear Medicine (EJNMMI) [3]
Annual cardiovascular deaths worldwide ~19 million European Society of Nuclear Medicine (EJNMMI) [3]
Adults aged 30‑79 with carotid plaque (global) ~816 million European Society of Cardiology (Cardiovascular Research) [2]
Adults aged 30‑79 with carotid plaque (Europe) ~137.6 million European Society of Cardiology (Cardiovascular Research) [2]
Adults with carotid stenosis (Europe) ~58 million European Society of Cardiology (Cardiovascular Research) [2]
Proportion of acute ischemic strokes attributable to carotid atherosclerosis ~20 % European Society of Cardiology (Cardiovascular Research) [2]

4. Plaque Vulnerability and Clinical Consequences

  • Intraplaque hemorrhage independently predicts stroke risk in individuals with subclinical atherosclerosis. European Society of Cardiology (Cardiovascular Research) 4
  • Carotid plaques contain a higher proportion of fibro‑fatty tissue, nodular calcifications, and projecting calcific nodules compared with coronary plaques, reflecting site‑specific composition. European Society of Cardiology (Cardiovascular Research) 4

5. Thrombotic Mechanisms

  • Plaque rupture exposes collagen, lipids, and smooth‑muscle cells to circulating blood, triggering platelet activation and coagulation. American Heart Association (Circulation) 1
  • Release of tissue factor from the ruptured plaque initiates thrombosis, leading to coronary occlusion and acute myocardial infarction or ischemic stroke. American Heart Association (Circulation) 1

6. Risk‑Factor Management

  • Effective hypertension control reduces arterial stiffness, lowers central systolic blood pressure, and preserves coronary perfusion pressure. American Heart Association (Circulation) 1
  • Modulation of the renin‑angiotensin‑aldosterone system and sympathetic nervous system mitigates vascular and myocardial damage. American Heart Association (Circulation) 1
  • Statin therapy remains the cornerstone of dyslipidaemia treatment and primary prevention, complemented by anticoagulant and antiplatelet strategies. European Society of Nuclear Medicine (EJNMMI) 3

7. Imaging and Surveillance

 ^18F‑FDG PET imaging quantifies plaque inflammation; higher tracer uptake reflects increased inflammatory activity within atherosclerotic lesions. *European Society of Nuclear Medicine** (EJNMMI) 3

  • Carotid plaque is defined as a focal structure encroaching ≥0.5 mm into the lumen or occupying ≥50 % of the vessel diameter, or any focal thickening deemed atherosclerotic. European Society of Cardiology (European Heart Journal) 5

8. Post‑Revascularization Evaluation

  • After coronary revascularization, systematic investigation of the acute event etiology—including Holter ECG, echocardiography, and aortic imaging—guides appropriate adjunctive therapy, particularly anticoagulation. European Society of Cardiology (European Heart Journal) 5

Evidence strength: not explicitly graded in the cited sources; recommendations are based on peer‑reviewed observational and mechanistic studies (generally Level B evidence).

Pathophysiology and Clinical Consequences of Atherosclerosis

Initiation of Lesions

  • Atherosclerosis is a chronic inflammatory disease that begins with lipid accumulation in the arterial intima and progresses through defined stages from fatty streaks to plaques that can rupture and cause thrombotic occlusion【6】【7】【8】.
  • The earliest detectable lesion is the fatty streak, representing an accumulation of lipid‑laden macrophages (foam cells) within the intima of medium‑ and large‑diameter arteries【6】【7】【8】.
  • Fatty streaks are already present in roughly half of pediatric individuals and in the majority of young adults, indicating that lesion formation starts early in life【6】.

Progression to Fibrous Plaques

  • Ongoing lipid deposition drives proliferation and migration of macrophages and vascular smooth‑muscle cells from the media into the intima, amplifying the lesion burden【6】【7】【8】.
  • The prevalence of fibrous plaques rises markedly with age, from about 8 % in childhood to approximately 69 % in early adulthood【6】.

Influence of Cardiovascular Risk Factors

  • Elevated low‑density lipoprotein (LDL) cholesterol, hypertension, smoking, diabetes, and obesity are each directly linked to the presence and extent of atherosclerotic lesions in individuals aged roughly 15–34 years【6】【9】.
  • The overall burden of atherosclerotic lesions increases exponentially as the number of concurrent risk factors rises【6】.
  • For every 10–15 mg/dL rise in non‑HDL cholesterol, an additional year of vascular “aging” is observed, underscoring the dose‑response relationship between lipid levels and arterial deterioration【10】.

Plaque Vulnerability and Complications

  • Advanced fibrous plaques become prone to rupture when they develop a large lipid‑rich necrotic core, a thinned fibrous cap, and are subjected to hemodynamic stress【6】.
  • Activated macrophages and T‑lymphocytes at the plaque shoulder up‑regulate metalloproteinases, which degrade extracellular matrix and thin the fibrous cap, facilitating rupture【11】.
  • Plaque rupture initiates a cascade of thrombotic events that can occlude the artery and precipitate myocardial infarction or ischemic stroke【6】【7】【8】.

Alternative Mechanisms of Acute Ischemic Events

  • Neovascularization within plaques can cause intraplaque hemorrhage, swelling, and luminal narrowing, leading to acute ischemic presentations【6】【7】【8】.
  • Intense focal coronary artery spasm (Prinzmetal’s angina) or diffuse microvascular dysfunction represent less common pathways to myocardial ischemia, independent of overt plaque rupture【11】.

REFERENCES